DOI: https://doi.org/10.26641/2307-0404.2015.3.53695

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.

V. A. Vasylenko

Abstract


The feature of chronic heart failure (CHF) in elderly people is increasing incidence of heart failure with preserved left ventricular ejection fraction (LVEF) which is associated with age. Such patients account for almost half of the total number of patients with heart failure. Cardiorenal syndrome (CRS) is associated with an increased risk of mortality in patients with CHF. The impact of CRS on the structural and functional condition of the heart in these patients is studied insufficiently. The study involved 103 patients with CHF II-IV NYHA with preserved LVEF (>45%) and CRS (hemoglobin <120 g/l and <GFR 60 mL/min/1,73m2 (MDRD). It is established that during progression of anemia and diastolic dysfunction development of concentric hypertrophy is observed, it is accompanied by deterioration of LV systolic function, namely by the increase of end-systolic volume and decrease in the degree of  LV fractional shortening size.


Keywords


chronic heart failure; preserved left ventricular ejection fraction; remodeling; echocardiography

Full Text:

PDF

References


Ronco C, McCullough P, Anker SD, et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus con-ference of the acute dialysis quality initiative. Eur Heart J 2010;31(6):703-11. 2. Cheng S, Xanthakis V, Sullivan LM, et al. Cor-rela¬tes of Echocardiographic Indices of Cardiac Remodeling Over the Adult Life Course: Longitudinal Observations from the Framingham Heart Study. Circu-lation 2010;122(6):570-8. 3. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS. Epi¬demiology and clinical course of heart failure with pre-served ejection fraction. Eur J Heart Fail 2011;13:18–28. 4. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. De¬veloped in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33(14):1787–847. 5. von Haehling S, Anker SD. Cardio-renal anemia syndrome. Contrib Nephrol. 2011;171:266-73. 6. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epide-miology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317–27. 7. Komajda M, Lam CS. Heart failure with preser-ved ejection fraction: a clinical dilemma. Eur. Heart. J. 2014;35:1022-32. 8. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137–46. 9. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with pre¬served ejection in a population-based study. N Engl. J. Med. 2006;355:260–9. 10. Ganau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992;19:1550-8. 11. Owan TE, Hodge Do, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and out-come of heart failure with preserved ejection fraction. N Engl. J. Med. 2006;355:251–9.


GOST Style Citations


1. Acute Dialysis Quality Initiative (ADQI) con-sensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality ini-tiative / C. Ronco, P. McCullough, S.D. Anker [et al.] // Eur. Heart J. – 2010. – Vol. 31, N 6. – P. 703-711. 2. Correlates of Echocardiographic Indices of Car-diac Remodeling Over the Adult Life Course: Longi-tudinal Observations from the Framingham Heart Study / S. Cheng, V. Xanthakis, L.M. Sullivan [et al.] // Circu-lation. – 2010. – Vol. 122, N 6. – P. 570-578. 3. Epidemiology and clinical course of heart failure with preserved ejection fraction / C.S. Lam, E. Donal, E. Kraigher-Krainer, R.S. Vasan // Eur. J. Heart Fail. – 2011. – Vol. 13. – P. 18-28. 4. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC // Eur. Heart J. – 2012. – Vol. 33, N 14. – P. 1787-1847. 5. von Haehling S. Cardio-renal anemia syndrome / S. von Haehling, S.D. Anker // Contrib. Nephrol. – 2011. – Vol. 171. – P. 266-273. 6. Hogg K. Heart failure with preserved left ventri-cular systolic function; epidemiology, clinical characte-ristics, and prognosis / K. Hogg, K. Swedberg, J. McMur-ray // J. Am. Coll. Cardiol. – 2004. – Vol. 43. – P. 317-327. 7. Komajda M. Heart failure with preserved ejection fraction: a clinical dilemma / M. Komajda, C.S. Lam // Eur. Heart J. – 2014. – Vol. 35. – P. 1022-1032. 8. Mosterd A. Clinical epidemiology of heart failure // A. Mosterd, A.W. Hoes // Heart – 2007. – Vol. 93 – P. 1137-1146. 9. Outcome of heart failure with preserved ejection in a population-based study / R.S. Bhatia, J.V. Tu, D.S. Lee [et al.] // N. Engl. J. Med. – 2006. – Vol. 355. – P. 260-269. 10. Patterns of left ventricular hypertrophy and geo-met¬ric remodelling in essential hypertension / A. Ganau, R.B. Devereux, M.J. Roman [et al.] // J. Am. Coll. Car¬diol. – 1992. – Vol. 19 – P. 1550-1558. 11. Trends in prevalence and outcome of heart failure with preserved ejection fraction / T.E. Owan, D. Hodge, R.M. Herges [et al.] // N. Engl. J. Med. – 2006. – Vol. 355. – P. 251-259.




 

This work is licensed under a Creative Commons Attribution 4.0 International License